|
Autologous graft in extensive myomectomies |
2008-09-12 |
HMG_VC |
|
Mebendazole compared with secnidazole-adult giardiasis-Phase III |
2010-04-21 |
HMC_FINLAY |
|
Multimodal anesthesia for beating heart surgery |
2012-06-09 |
HHA |
|
Amniotic Membrane Transplantation vs Conjunctival–Limbal Autograft for Primary Pterygium |
2009-07-03 |
HHA |
|
Prebiotics and probiotics in the treatment of type 2 diabetes |
06/12/2022 |
HHA |
|
Dietzia safety study |
17/04/2023 |
HHA |
|
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |
16/02/2017 |
HGM |
|
CONTROLLED, DOUBLE-BLIND, RANDOMIZED, MULTICENTER, FASE IIIb TRIAL DESIGNED TO EVALUATE THE EFFICACY AND TOLERABILITY OF THE FIXED COMBINATION OF THIOCOLCHICOSIDE PLUS DICLOFENAC POTASSIUM IN ACUTE PAINFUL MUSCLE CONTRACTURE |
2013-06-20 |
GUTIS |
|
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants. |
2008-07-29 |
FINLAY |
|
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique. |
2008-09-12 |
FINLAY |
|
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. |
2008-09-19 |
FINLAY |
|
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers. |
2008-07-29 |
FINLAY |
|
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age. |
2008-07-29 |
FINLAY |
|
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. |
2008-07-29 |
FINLAY |
|
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. |
2008-07-29 |
FINLAY |
|
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain. |
2008-09-12 |
FINLAY |
|
Study of the tetanus vaccine vax-TET®-5 |
2013-06-10 |
FINLAY |
|
Study of the meningococcal ACW135 polysaccharide vaccine |
04/12/2015 |
FINLAY |
|
Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba. |
11/10/2013 |
FINLAY |
|
SOBERANA PLUS TURIN |
12/11/2021 |
FINLAY |
